INTERLEUKIN-8 IN SEPSIS - RELATION TO SHOCK AND INFLAMMATORY MEDIATORS

被引:277
作者
HACK, CE
HART, M
VANSCHIJNDEL, RJMS
EERENBERG, AJM
NUIJENS, JH
THIJS, LG
AARDEN, LA
机构
[1] UNIV AMSTERDAM,EXPTL CLIN IMMUNOL LAB,1066 CX AMSTERDAM,NETHERLANDS
[2] FREE UNIV AMSTERDAM HOSP,MED INTENS CARE UNIT,1081 HV AMSTERDAM,NETHERLANDS
关键词
D O I
10.1128/IAI.60.7.2835-2842.1992
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Because of its neutrophil-activating properties, interleukin-8 (IL-8) may play an important role in the pathophysiology of sepsis. We measured circulating IL-8 levels in 47 patients with clinical sepsis. Levels on admission were elevated in 42 of the 47 patients (89%) and were comparable in patients with gram-positive or gram-negative infections. Patients with shock had significantly higher IL-8 levels than normotensive patients (P = 0.0014, Wilcoxon-Mann-Whitney test), whereas no differences in IL-8 levels were found between patients with or without adult respiratory distress syndrome. Patients who died had higher IL-8 levels on admission than the patients who survived. The largest differences in IL-8 levels between survivors and nonsurvivors was found when only patients with positive cultures were considered (P = 0.0342). IL-8 levels appeared to correlate significantly with lactate levels and inversely with leukocyte and platelet numbers and mean arterial pressure. In addition, the IL-8 level in the sepsis patients was found to correlate significantly with levels of IL-6, elastase-alpha-1-antitrypsin, and C3a. Serial observations revealed that in most patients IL-8 levels decreased, irrespective of the outcome. Thus, our results demonstrate that IL-8 levels are increased in most patients with sepsis and correlate with some important clinical, biochemical, and inflammatory parameters. These findings suggest a role for IL-8 in the pathophysiology of sepsis.
引用
收藏
页码:2835 / 2842
页数:8
相关论文
共 57 条
[1]  
ABBINK JJ, 1991, THROMB HAEMOSTASIS, V65, P32
[2]   A RECOMBINANT HUMAN RECEPTOR ANTAGONIST TO INTERLEUKIN-1 IMPROVES SURVIVAL AFTER LETHAL ENDOTOXEMIA IN MICE [J].
ALEXANDER, HR ;
DOHERTY, GM ;
BURESH, CM ;
VENZON, DJ ;
NORTON, JA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (04) :1029-1032
[3]   NEUTROPHIL-ACTIVATING PEPTIDE-1 INTERLEUKIN-8, A NOVEL CYTOKINE THAT ACTIVATES NEUTROPHILS [J].
BAGGIOLINI, M ;
WALZ, A ;
KUNKEL, SL .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (04) :1045-1049
[4]   PASSIVE-IMMUNIZATION AGAINST CACHECTIN TUMOR NECROSIS FACTOR PROTECTS MICE FROM LETHAL EFFECT OF ENDOTOXIN [J].
BEUTLER, B ;
MILSARK, IW ;
CERAMI, AC .
SCIENCE, 1985, 229 (4716) :869-871
[5]  
BEUTLER B, 1987, NEW ENGL J MED, V316, P379
[6]   CATALYZED REPORTER DEPOSITION, A NOVEL METHOD OF SIGNAL AMPLIFICATION - APPLICATION TO IMMUNOASSAYS [J].
BOBROW, MN ;
HARRIS, TD ;
SHAUGHNESSY, KJ ;
LITT, GJ .
JOURNAL OF IMMUNOLOGICAL METHODS, 1989, 125 (1-2) :279-285
[7]   THE PATHOGENESIS OF SEPSIS [J].
BONE, RC .
ANNALS OF INTERNAL MEDICINE, 1991, 115 (06) :457-469
[8]  
BRAKENHOFF JPJ, 1990, J IMMUNOL, V145, P561
[9]  
BRAKENHOFF JPJ, 1989, J IMMUNOL, V143, P1175
[10]   NEUTROPHIL ACTIVATING FACTOR (NAF) INDUCES POLYMORPHONUCLEAR LEUKOCYTE ADHERENCE TO ENDOTHELIAL-CELLS AND TO SUBENDOTHELIAL MATRIX PROTEINS [J].
CARVETH, HJ ;
BOHNSACK, JF ;
MCINTYRE, TM ;
BAGGIOLINI, M ;
PRESCOTT, SM ;
ZIMMERMAN, GA .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 162 (01) :387-393